123 related articles for article (PubMed ID: 11813890)
1. What's new in the biology and treatment of undifferentiated carcinoma of nasopharyngeal type?
Carbone A; Dolcetti R; Shaha AR; Gloghini A; Molinari R; Rinaldo A; Boiocchi M; Wei WI; Ferlito A
Acta Otolaryngol; 2001 Dec; 121(8):884-95. PubMed ID: 11813890
[No Abstract] [Full Text] [Related]
2. Nasopharyngeal carcinoma.
Kamran SC; Riaz N; Lee N
Surg Oncol Clin N Am; 2015 Jul; 24(3):547-61. PubMed ID: 25979399
[TBL] [Abstract][Full Text] [Related]
3. Can plasma Epstein-Barr virus DNA levels be used to monitor nasopharyngeal carcinoma progression?
Farrell PJ
Nat Clin Pract Oncol; 2005 Jan; 2(1):14-5. PubMed ID: 16264847
[No Abstract] [Full Text] [Related]
4. Nasopharyngeal carcinoma. Biology, natural history, and therapeutic implications.
Cvitkovic E; Bachouchi M; Armand JP
Hematol Oncol Clin North Am; 1991 Aug; 5(4):821-38. PubMed ID: 1890068
[TBL] [Abstract][Full Text] [Related]
5. Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia.
Pathmanathan R; Prasad U; Chandrika G; Sadler R; Flynn K; Raab-Traub N
Am J Pathol; 1995 Jun; 146(6):1355-67. PubMed ID: 7778675
[TBL] [Abstract][Full Text] [Related]
6. Systemic treatment strategies and therapeutic monitoring for advanced nasopharyngeal carcinoma.
Ma BB; Chan AT
Expert Rev Anticancer Ther; 2006 Mar; 6(3):383-94. PubMed ID: 16503855
[TBL] [Abstract][Full Text] [Related]
7. Detection of Epstein-Barr virus DNA in the peripheral-blood cells of patients with nasopharyngeal carcinoma: relationship to distant metastasis and survival.
Lin JC; Chen KY; Wang WY; Jan JS; Liang WM; Tsai CS; Wei YH
J Clin Oncol; 2001 May; 19(10):2607-15. PubMed ID: 11352952
[TBL] [Abstract][Full Text] [Related]
8. Sarcomatoid carcinoma of the upper aerodigestive tract: an immunohistochemical analysis demonstrating latent Epstein-Barr virus in a subset of eight cases.
Etit D; Altinel D; Bayol U; Tan A; Cumurcu S
Indian J Pathol Microbiol; 2010; 53(4):750-6. PubMed ID: 21045407
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA.
Stevens SJ; Verkuijlen SA; Hariwiyanto B; Harijadi ; Paramita DK; Fachiroh J; Adham M; Tan IB; Haryana SM; Middeldorp JM
Int J Cancer; 2006 Aug; 119(3):608-14. PubMed ID: 16572427
[TBL] [Abstract][Full Text] [Related]
10. Focus on nasopharyngeal carcinoma.
Lo KW; To KF; Huang DP
Cancer Cell; 2004 May; 5(5):423-8. PubMed ID: 15144950
[No Abstract] [Full Text] [Related]
11. Treatment of nasopharyngeal carcinoma.
Kraiphibul P; Atichartakarn V
J Med Assoc Thai; 1992 Aug; 75(8):435-44. PubMed ID: 1300360
[TBL] [Abstract][Full Text] [Related]
12. Lymphoid cell infiltration into Epstein-Barr virus-positive nasopharyngeal carcinomas.
Shpitzer T; Kerrebijn JD; Freeman JL; Hartwick W; Saiki Y; Irish JC; Macmillan CM; Dosch HM
Otolaryngol Head Neck Surg; 2001 Feb; 124(2):188-94. PubMed ID: 11226955
[TBL] [Abstract][Full Text] [Related]
13. IgA antibodies against the Epstein-Barr nuclear antigen1 as a valuable biomarker for the diagnosis of nasopharyngeal carcinoma in Tunisian patients.
Ayadi W; Karray-Hakim H; Feki L; Khabir A; Boudawara T; Ghorbel A; Daoud J; Frikha M; Hammami A
J Med Virol; 2009 Aug; 81(8):1412-21. PubMed ID: 19551836
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus (EBV) latent membrane protein-1-specific cytotoxic T lymphocytes targeting EBV-carrying natural killer cell malignancies.
Demachi-Okamura A; Ito Y; Akatsuka Y; Tsujimura K; Morishima Y; Takahashi T; Kuzushima K
Eur J Immunol; 2006 Mar; 36(3):593-602. PubMed ID: 16479544
[TBL] [Abstract][Full Text] [Related]
15. [Latency of Epstein-Barr virus and its relationship to nasopharyngeal carcinomas].
You S; Yao K; Cao Y
Zhonghua Zhong Liu Za Zhi; 1996 Jan; 18(1):23-6. PubMed ID: 8732106
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus-targeted immunotherapy for nasopharyngeal carcinoma.
Masmoudi A; Toumi N; Khanfir A; Kallel-Slimi L; Daoud J; Karray H; Frikha M
Cancer Treat Rev; 2007 Oct; 33(6):499-505. PubMed ID: 17544585
[TBL] [Abstract][Full Text] [Related]
17. Epstein-barr virus-associated lymphoepithelioma-like carcinoma of mandible.
Shet T; Arora B; Laskar S; Basak R; Kane S; Kurkure P
Pediatr Dev Pathol; 2009; 12(2):152-5. PubMed ID: 18457481
[TBL] [Abstract][Full Text] [Related]
18. Modern treatment for nasopharyngeal carcinoma: current status and prospects.
Rottey S; Madani I; Deron P; Van Belle S
Curr Opin Oncol; 2011 May; 23(3):254-8. PubMed ID: 21330921
[TBL] [Abstract][Full Text] [Related]
19. High frequency of Epstein Barr virus latent membrane protein-1 30 bp deletion in a series of pediatric malignancies in Argentina.
Chabay P; De Matteo E; Merediz A; Preciado MV
Arch Virol; 2004 Aug; 149(8):1515-26. PubMed ID: 15290377
[TBL] [Abstract][Full Text] [Related]
20. EBV specific antibody-based and DNA-based assays in serologic diagnosis of nasopharyngeal carcinoma.
Chan KH; Gu YL; Ng F; Ng PS; Seto WH; Sham JS; Chua D; Wei W; Chen YL; Luk W; Zong YS; Ng MH
Int J Cancer; 2003 Jul; 105(5):706-9. PubMed ID: 12740922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
